Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Akela Pharma Inc. AKLPF

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."


GREY:AKLPF - Post by User

Post by Biostocks01on Jul 18, 2012 9:03am
330 Views
Post# 20124840

Akela Pharma, Inc. Announces Board of Director Tra

Akela Pharma, Inc. Announces Board of Director Tra

AUSTIN, TX, July 17, 2012 /CNW Telbec/ - Akela Pharma, Inc. (TSX: AKL)
 today announced that Mr. Robert W. Rieder is stepping down as Chairman
 of the Board and as a member of the Board of Directors of Akela Pharma,
 Inc. to continue his focus as CEO and Director of ESSA Pharma, Inc.


Akela also announced that Mr. Seth E. Lemler, of Lemler Capital
 Advisors, LLC, has joined Akela's Board of Directors and has been named
 Chairman of the Board.


Mr. Rieder joined the Board of Akela in May of 2009 and was elected as
 Chairman of the Board in August 2009.  "Bob has served and dedicated
 many years as Chairman of the Board of Akela and has overseen the
 Company through some challenging periods" said Mr. Rudy Emmelot,
 President & CEO of Akela. "We are very thankful to Bob for his
 steadfastness and leadership over the past several years and wish him
 the best of success at ESSA Pharma."


The Company is proud to welcome Mr. Seth Lemler to the Akela Board of
 Directors as Chairman of the Board. Mr. Lemler currently runs Lemler
 Capital Advisors and has a distinguished career that has encompassed
 over 25 years of experience including working for Versa Capital
 Management, Inc., Morgan Joseph & Co. and Ladenburg Thalmann & Co. Mr.
 Lemler has advised businesses in industries ranging from health care
 and manufacturing to technology and consumer products. Mr. Lemler's
 breadth of experience spans nearly all aspects of operations and
 finance. "We are proud to have Seth join the Akela Board of Directors
 and serve as Chairman of the Board" said Mr. Emmelot. "Seth brings
 tremendous experience and expertise to Akela having advised numerous
 businesses on strategic planning and execution."


Mr. Lemler holds a Masters of Business Administration from the
 University of Chicago's Booth Graduate School of Business and is a
 graduate of the Massachusetts Institute of Technology, where he earned
 a B.S. degree in Chemical Engineering.


About Akela Pharma, Inc

Bio

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse